Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteazevan.com
CategoryBioTech
Phone(610) 419 1057
Employees
Founded1999
DescriptionDrug development company

Offices

Bethlehem, USA
116 Research Drive
Bethlehem, PA, 18015
USA

People

CEO
Board Member
Board of Directors

Funding

TOTAL $2.21M
FUNDING TOTAL $2.21M
Partial Close, 10/2013
$2.21M

Tags

Azevan Pharmaceuticals

Azevan Pharmaceuticals, Inc., a clinical stage, small molecule drug development company, develops therapeutics to treat disorders of stress, mood, and behavior. The company specializes in clinical compounds that selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of major depression, intermittent explosive disorder, impulse control/anger disorders, and post-traumatic stress disorder (PTSD). Its products include SRX251 and SRX246 CNS-penetrating V1a receptor antagonists that are orally bioavailable. The company’s SRX246 and SRX251 are developed for stress-related CNS disorders, including depression, PTSD, and intermittent explosive disorders. Azevan Pharmaceuticals, Inc. was formerly known as Serenix Pharmaceuticals, LLC and changed its name to Azevan Pharmaceuticals, Inc. in January 2002. The company was founded in 1999 and is based in Bethlehem, Pennsylvania.

Recent Milestones

Videos

Screenshots

Azevan Pharmaceuticals screenshot
Above: Homepage
Uploaded: 10/21/13

Sources

  1. SEC (sec.gov) [edit]
Edit This Page
Last Edited 12/20/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy